Related references
Note: Only part of the references are listed.Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation
Y. Umezawa et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity
C. L. Vermont et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Visceral varicella zoster virus infection after allogeneic stem cell transplantation
N. Doki et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group
K. Oshima et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Marcie Tomblyn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
J. Styczynski et al.
BONE MARROW TRANSPLANTATION (2009)
Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation
Kristel Vandenbosch et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation
A. Bjorklund et al.
BONE MARROW TRANSPLANTATION (2007)
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study
M Boeckh et al.
BLOOD (2006)
Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation
B Hackanson et al.
CLINICAL TRANSPLANTATION (2005)
Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults
H Mommeja-Marin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Latency and reactivation of human cytomegalovirus
JGP Sissons et al.
JOURNAL OF INFECTION (2002)
Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation
MC Dignani et al.
BONE MARROW TRANSPLANTATION (2002)
Viral infections in children undergoing hematopoietic stem cell transplant
HC Maltezou et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation
TF Leung et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
